[시장보고서]ADME 독성 시험 시장 규모, 점유율, 동향 분석 보고서 : 기술별, 용도별, 방법별, 지역별, 부문별 예측(2025-2030년)

ADME 독성 시험 시장 규모, 점유율, 동향 분석 보고서 : 기술별, 용도별, 방법별, 지역별, 부문별 예측(2025-2030년)

ADME Toxicology Testing Market Size, Share & Trends Analysis Report By Technology (Cell Culture Tech, High Throughput Tech, Molecular Imaging), By Application, By Method, By Region, And Segment Forecasts, 2025 - 2030

상품코드 : 1587802

리서치사 : Grand View Research

발행일 : 2024년 10월

페이지 정보 : 영문 120 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,830,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,315,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,283,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

ADME 독성 시험 시장 성장 및 동향:

Grand View Research, Inc.의 최신 보고서에 따르면 ADME 독성 시험 세계 시장 규모는 2025년부터 2030년까지 연평균 10.0%의 CAGR로 확대되어 2030년에는 114억 4,000만 달러에 달할 것으로 예상됩니다.

제약회사들이 보다 적절한 독성 시험 방법을 채택하여 후기 단계의 약물 실패를 확인해야 할 필요성이 증가함에 따라 이 시장의 수익 창출을 촉진할 것으로 예상됩니다.

흡수-분포-대사-배설(ADME) 독성 시험은 임상시험에서 분자가 유발하는 독성 반응을 화학적, 약리학적, 유전적 요인 및 전신 반응에 대해 시험하는 데 사용됩니다. 이러한 독성 시험 절차는 투여 시 체내 독성 반응을 제한하거나 예방하는 효과적인 의약품 개발에 도움이 됩니다. 독성 수준은 약물과 숙주 사이의 거의 실시간 반응을 나타내는 자연에 가까운 조건에서 수행되는 일련의 테스트 결과를 기반으로 결정됩니다.

2017년 현재 ADME 독성 시험 분야의 약 43.0%가 세포배양 기술을 기반으로 수행되고 있습니다. 세포배양 기술은 자연에 가까운 조건과 세포 수준에서 얻을 수 있는 정확한 결과 등의 장점으로 인해 널리 채택되고 있습니다.

이러한 분석은 여러 유형의 독성 반응 또는 독성 반응이 발생할 수 있는 시스템에 대해 수행됩니다. 독성 시험에는 전신 독성, 신장 독성, 간 독성, 신경 독성 및 기타 생체 조직에서 발생할 수 있는 독성 등이 있습니다. 이러한 시험 방법의 추세는 현재 진행 중이고, 많은 제약회사들이 이러한 시험 방법을 도입할 것으로 보입니다. 이는 신약 개발 과정을 가속화하고 시장 성장을 촉진할 것으로 보입니다.

ADME 독성 시험 시장 보고서 하이라이트

후기 단계의 의약품 실패 비율이 증가하여 의약품 개발을 위한 귀중한 시간과 투자 손실이 시장을 주도하고 있습니다. 또한, OMICS 기술의 성장과 채택 증가는 향후 몇 년 동안 수익 창출을 촉진할 것으로 예상됩니다.
북미는 많은 제약회사들이 새로운 분자의 상업적 출시를 위해 경쟁하고 있어 ADME 독성 시험의 가장 큰 시장으로 부상하고 있습니다.
아시아태평양과 라틴아메리카의 신흥국 시장은 많은 다국적 기업과 현지 기업들이 시장 진입을 목표로 하고 있기 때문에 크게 성장할 것으로 예상됩니다. 또한, 혁신과 성장 기회가 있는 시장에서 입지를 강화하기 위해 노력하고 있습니다.

지역 시장 대시보드
시장 규모와 예측 및 동향 분석, 2018-2030년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 태국
- 한국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제8장 경쟁 상황

진출 기업
기업 시장 상황 분석, 2024년
진출 기업 개요
- Thermo Fisher Scientific Inc.
- Danaher
- Charles River Laboratories
- Promega Corporation
- Agilent Technologies, Inc.
- Curia Global, Inc.
- Dassault Systemes
- Catalent, Inc
- Labcorp
- Eurofins Scientific
- Miltenyi Biotec
- IQVIA Inc.

ksm

영문 목차

영문목차

ADME Toxicology Testing Market Growth & Trends:

The global ADME toxicology testing market size is expected to reach USD 11.44 billion by 2030, expanding at a CAGR of 10.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. Factors such as increased need to check late-stage drug failures with the adoption of more appropriate toxicity testing methods by pharmaceutical companies are expected to aid revenue generation for the market.

Absorption, distribution, metabolism, and excretion (ADME) toxicology testing is used to test toxic reactions caused by molecules in clinical trials on factors and systemic reactions such as chemical, pharmaceutical, and genetic. These toxicology testing procedures help in effective drug development, which limits or prevents toxic reactions to the body when administered. Toxicity levels are decided on the results of a series of tests conducted in near-natural conditions, which represent almost real-time reactions between the drug and the host.

As of 2017, approximately 43.0% of ADME toxicology testing areas carried out are based on cell culture tech. Cell culture technology is adopted widely owing to advantages such as near-natural conditions and accurate results obtained at a cellular level.

These assays are conducted for several types of toxic reactions or systems where toxic reactions might take place. Some of the toxicity tests are systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and other toxicities that might result in living tissue. Advancements in testing methods are underway and this trend is likely to be picked up by many companies developing drug molecules. This will speed up the drug discovery process and boost the market growth.

ADME Toxicology Testing Market Report Highlights:

The market is driven by an increasing ratio of late-stage drug failures, resulting in loss of valuable time and investment for drug development. Growth and increasing adoption of OMICS technology is also expected to boost revenue generation in the coming years
North America is the largest market for ADME toxicology testing owing to the presence of a large number of pharmaceutical companies competing for the commercial launch of novel molecules
Developing regions of Asia Pacific and Latin America are set to grow considerably as many multinational and local players are striving to enter the market. They are also looking to improve their hold in markets that present innovation and growth opportunities

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Segment Definitions
- 1.2.1. Technology
- 1.2.2. Method
- 1.2.3. Application
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
- 1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. High rate of late-stage drug failure
  - 3.2.1.2. Increasing need for novel drug molecules
  - 3.2.1.3. Technological advancements in ADME studies
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. Challenges pertaining to in vitro ADME studies
3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis

Chapter 4. ADME Toxicology Testing Market: Technology Business Analysis

4.1. Segment Dashboard
4.2. Global ADME Toxicology Testing Market Movement Analysis
4.3. Global ADME Toxicology Testing Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
4.4. Cell Culture Tech
- 4.4.1. Global Cell Culture Tech Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. High Throughput Tech
- 4.5.1. Global High Throughput Tech Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Molecular Imaging
- 4.6.1. Global Molecular Imaging Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. OMICS Tech
- 4.7.1. Global OMICS Tech Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. ADME Toxicology Testing Market: Method Business Analysis

5.1. Segment Dashboard
5.2. Global ADME Toxicology Testing Market Movement Analysis
5.3. Global ADME Toxicology Testing Market Size & Trend Analysis, by Method, 2018 to 2030 (USD Million)
5.4. Cellular Assay
- 5.4.1. Global Cellular Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Biochemical Assay
- 5.5.1. Global Biochemical Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. In Silico
- 5.6.1. Global In Silico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Ex-vivo
- 5.7.1. Global Ex-vivo Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. ADME Toxicology Testing Market: Application Business Analysis

6.1. Segment Dashboard
6.2. Global ADME Toxicology Testing Market Movement Analysis
6.3. Global ADME Toxicology Testing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Systemic Toxicity
- 6.4.1. Global Systemic Toxicity Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Renal Toxicity
- 6.5.1. Global Renal Toxicity Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Hepatotoxicity
- 6.6.1. Global Hepatotoxicity Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Neurotoxicity
- 6.7.1. Global Neurotoxicity Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Others
- 6.8.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. ADME Toxicology Testing Market: Regional Estimates & Trend Analysis by Technology, Method, & Application

7.1. Regional Market Dashboard
7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
7.3. North America
- 7.3.1. North America ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. U.S.
  - 7.3.2.1. Key Country Dynamics
  - 7.3.2.2. Competitive Scenario
  - 7.3.2.3. Regulatory Framework
  - 7.3.2.4. U.S. ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Canada
  - 7.3.3.1. Key Country Dynamics
  - 7.3.3.2. Competitive Scenario
  - 7.3.3.3. Regulatory Framework
  - 7.3.3.4. Canada ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.4. Mexico
  - 7.3.4.1. Key Country Dynamics
  - 7.3.4.2. Competitive Scenario
  - 7.3.4.3. Regulatory Framework
  - 7.3.4.4. Mexico ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Europe
- 7.4.1. Europe ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. UK
  - 7.4.2.1. Key Country Dynamics
  - 7.4.2.2. Competitive Scenario
  - 7.4.2.3. Regulatory Framework
  - 7.4.2.4. UK ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Germany
  - 7.4.3.1. Key Country Dynamics
  - 7.4.3.2. Competitive Scenario
  - 7.4.3.3. Regulatory Framework
  - 7.4.3.4. Germany ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. France
  - 7.4.4.1. Key Country Dynamics
  - 7.4.4.2. Competitive Scenario
  - 7.4.4.3. Regulatory Framework
  - 7.4.4.4. France ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.5. Italy
  - 7.4.5.1. Key Country Dynamics
  - 7.4.5.2. Competitive Scenario
  - 7.4.5.3. Regulatory Framework
  - 7.4.5.4. Italy ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.6. Spain
  - 7.4.6.1. Key Country Dynamics
  - 7.4.6.2. Competitive Scenario
  - 7.4.6.3. Regulatory Framework
  - 7.4.6.4. Spain ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.7. Denmark
  - 7.4.7.1. Key Country Dynamics
  - 7.4.7.2. Competitive Scenario
  - 7.4.7.3. Regulatory Framework
  - 7.4.7.4. Denmark ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.8. Sweden
  - 7.4.8.1. Key Country Dynamics
  - 7.4.8.2. Competitive Scenario
  - 7.4.8.3. Regulatory Framework
  - 7.4.8.4. Sweden ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.9. Norway
  - 7.4.9.1. Key Country Dynamics
  - 7.4.9.2. Competitive Scenario
  - 7.4.9.3. Regulatory Framework
  - 7.4.9.4. Norway ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Asia Pacific
- 7.5.1. Asia Pacific ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. Japan
  - 7.5.2.1. Key Country Dynamics
  - 7.5.2.2. Competitive Scenario
  - 7.5.2.3. Regulatory Framework
  - 7.5.2.4. Japan ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. China
  - 7.5.3.1. Key Country Dynamics
  - 7.5.3.2. Competitive Scenario
  - 7.5.3.3. Regulatory Framework
  - 7.5.3.4. China ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. India
  - 7.5.4.1. Key Country Dynamics
  - 7.5.4.2. Competitive Scenario
  - 7.5.4.3. Regulatory Framework
  - 7.5.4.4. India ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.5. Australia
  - 7.5.5.1. Key Country Dynamics
  - 7.5.5.2. Competitive Scenario
  - 7.5.5.3. Regulatory Framework
  - 7.5.5.4. Australia ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.6. Thailand
  - 7.5.6.1. Key Country Dynamics
  - 7.5.6.2. Competitive Scenario
  - 7.5.6.3. Regulatory Framework
  - 7.5.6.4. Thailand ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.7. South Korea
  - 7.5.7.1. Key Country Dynamics
  - 7.5.7.2. Competitive Scenario
  - 7.5.7.3. Regulatory Framework
  - 7.5.7.4. South Korea ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Latin America
- 7.6.1. Latin America ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. Brazil
  - 7.6.2.1. Key Country Dynamics
  - 7.6.2.2. Competitive Scenario
  - 7.6.2.3. Regulatory Framework
  - 7.6.2.4. Brazil ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. Argentina
  - 7.6.3.1. Key Country Dynamics
  - 7.6.3.2. Competitive Scenario
  - 7.6.3.3. Regulatory Framework
  - 7.6.3.4. Argentina ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. MEA
- 7.7.1. MEA ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.2. South Africa
  - 7.7.2.1. Key Country Dynamics
  - 7.7.2.2. Competitive Scenario
  - 7.7.2.3. Regulatory Framework
  - 7.7.2.4. South Africa ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.3. Saudi Arabia
  - 7.7.3.1. Key Country Dynamics
  - 7.7.3.2. Competitive Scenario
  - 7.7.3.3. Regulatory Framework
  - 7.7.3.4. Saudi Arabia ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.4. UAE
  - 7.7.4.1. Key Country Dynamics
  - 7.7.4.2. Competitive Scenario
  - 7.7.4.3. Regulatory Framework
  - 7.7.4.4. UAE ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.5. Kuwait
  - 7.7.5.1. Key Country Dynamics
  - 7.7.5.2. Competitive Scenario
  - 7.7.5.3. Regulatory Framework
  - 7.7.5.4. Kuwait ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Participant Categorization
8.2. Company Market Position Analysis, 2024
8.3. Participant's Overview
- 8.3.1. Thermo Fisher Scientific Inc.
  - 8.3.1.1. Overview
  - 8.3.1.2. Product Benchmarking
  - 8.3.1.3. Strategic Initiatives
- 8.3.2. Danaher
  - 8.3.2.1. Overview
  - 8.3.2.2. Financial Performance
  - 8.3.2.3. Product Benchmarking
  - 8.3.2.4. Strategic Initiatives
- 8.3.3. Charles River Laboratories
  - 8.3.3.1. Overview
  - 8.3.3.2. Financial Performance
  - 8.3.3.3. Product Benchmarking
  - 8.3.3.4. Strategic Initiatives
- 8.3.4. Promega Corporation
  - 8.3.4.1. Overview
  - 8.3.4.2. Financial Performance
  - 8.3.4.3. Product Benchmarking
  - 8.3.4.4. Strategic Initiatives
- 8.3.5. Agilent Technologies, Inc.
  - 8.3.5.1. Overview
  - 8.3.5.2. Financial Performance
  - 8.3.5.3. Product Benchmarking
  - 8.3.5.4. Strategic Initiatives
- 8.3.6. Curia Global, Inc.
  - 8.3.6.1. Overview
  - 8.3.6.2. Financial Performance
  - 8.3.6.3. Product Benchmarking
  - 8.3.6.4. Strategic Initiatives
- 8.3.7. Dassault Systemes
  - 8.3.7.1. Overview
  - 8.3.7.2. Financial Performance
  - 8.3.7.3. Product Benchmarking
  - 8.3.7.4. Strategic Initiatives
- 8.3.8. Catalent, Inc
  - 8.3.8.1. Overview
  - 8.3.8.2. Financial Performance
  - 8.3.8.3. Product Benchmarking
  - 8.3.8.4. Strategic Initiatives
- 8.3.9. Labcorp
  - 8.3.9.1. Overview
  - 8.3.9.2. Financial Performance
  - 8.3.9.3. Product Benchmarking
  - 8.3.9.4. Strategic Initiatives
- 8.3.10. Eurofins Scientific
  - 8.3.10.1. Overview
  - 8.3.10.2. Financial Performance
  - 8.3.10.3. Product Benchmarking
  - 8.3.10.4. Strategic Initiatives
- 8.3.11. Miltenyi Biotec
  - 8.3.11.1. Overview
  - 8.3.11.2. Financial Performance
  - 8.3.11.3. Product Benchmarking
  - 8.3.11.4. Strategic Initiatives
- 8.3.12. IQVIA Inc.
  - 8.3.12.1. Overview
  - 8.3.12.2. Financial Performance
  - 8.3.12.3. Product Benchmarking
  - 8.3.12.4. Strategic Initiatives

한글목차

ADME 독성 시험 시장 성장 및 동향:

ADME 독성 시험 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 시장 변수, 동향, 범위

제4장 ADME 독성 시험 시장 : 기술 비즈니스 분석

제5장 ADME 독성 시험 시장 : 방법 비즈니스 분석

제6장 ADME 독성 시험 시장 : 용도 비즈니스 분석

제7장 ADME 독성 시험 시장 : 기술, 방법, 용도별 지역 추정·동향 분석